JPY 434.0
(-0.46%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1.12 Billion JPY | 37.59% |
2022 | 819.9 Million JPY | -63.28% |
2021 | 2.23 Billion JPY | 9.72% |
2020 | 2.03 Billion JPY | -4.08% |
2019 | 2.12 Billion JPY | 14.74% |
2018 | 1.84 Billion JPY | 17.67% |
2017 | 1.57 Billion JPY | 60.83% |
2016 | 977.03 Million JPY | 74.63% |
2015 | 559.47 Million JPY | -37.17% |
2014 | 890.51 Million JPY | -11.62% |
2013 | 1 Billion JPY | -10.57% |
2012 | 1.12 Billion JPY | -7.32% |
2011 | 1.21 Billion JPY | 145.82% |
2010 | 494.55 Million JPY | 64.43% |
2009 | 300.77 Million JPY | 1321.32% |
2008 | 21.16 Million JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 891.02 Million JPY | 96.05% |
2024 Q3 | 655.77 Million JPY | -26.4% |
2024 Q1 | 454.49 Million JPY | 2.68% |
2023 Q3 | 477.03 Million JPY | 58.83% |
2023 Q2 | 300.33 Million JPY | 426.44% |
2023 FY | 1.12 Billion JPY | 37.59% |
2023 Q4 | 442.61 Million JPY | -7.21% |
2023 Q1 | -92 Million JPY | -123.38% |
2022 FY | 819.9 Million JPY | -63.28% |
2022 Q1 | 630.2 Million JPY | 126.48% |
2022 Q3 | -293.71 Million JPY | 46.11% |
2022 Q2 | -545.01 Million JPY | -186.48% |
2022 Q4 | 393.57 Million JPY | 234.0% |
2021 FY | 2.23 Billion JPY | 9.72% |
2021 Q2 | 831.49 Million JPY | 25.29% |
2021 Q1 | 663.68 Million JPY | 16.36% |
2021 Q3 | 459.62 Million JPY | -44.72% |
2021 Q4 | 278.25 Million JPY | -39.46% |
2020 FY | 2.03 Billion JPY | -4.08% |
2020 Q3 | 586.65 Million JPY | -2.29% |
2020 Q1 | 277.73 Million JPY | -33.99% |
2020 Q2 | 600.4 Million JPY | 116.18% |
2020 Q4 | 570.38 Million JPY | -2.77% |
2019 FY | 2.12 Billion JPY | 14.74% |
2019 Q2 | 772.32 Million JPY | 52.6% |
2019 Q1 | 506.12 Million JPY | 16.37% |
2019 Q3 | 422.43 Million JPY | -45.3% |
2019 Q4 | 420.77 Million JPY | -0.39% |
2018 Q4 | 434.93 Million JPY | -21.81% |
2018 FY | 1.84 Billion JPY | 17.67% |
2018 Q2 | 778.12 Million JPY | 875.65% |
2018 Q1 | 79.75 Million JPY | -79.34% |
2018 Q3 | 556.23 Million JPY | -28.52% |
2017 Q4 | 385.99 Million JPY | 7.66% |
2017 FY | 1.57 Billion JPY | 60.83% |
2017 Q3 | 358.51 Million JPY | -24.5% |
2017 Q2 | 474.82 Million JPY | 34.87% |
2017 Q1 | 352.06 Million JPY | 4.16% |
2016 Q1 | 161.7 Million JPY | 951.62% |
2016 FY | 977.03 Million JPY | 74.63% |
2016 Q4 | 338.01 Million JPY | 9.85% |
2016 Q3 | 307.69 Million JPY | 81.41% |
2016 Q2 | 169.61 Million JPY | 4.89% |
2015 Q1 | 90.65 Million JPY | -69.73% |
2015 Q2 | 307.63 Million JPY | 239.36% |
2015 Q3 | 145.81 Million JPY | -52.6% |
2015 FY | 559.47 Million JPY | -37.17% |
2015 Q4 | 15.37 Million JPY | -89.45% |
2014 Q2 | 423.11 Million JPY | 121.62% |
2014 Q1 | 190.91 Million JPY | -9.84% |
2014 FY | 890.51 Million JPY | -11.62% |
2014 Q4 | 299.5 Million JPY | 1401.08% |
2014 Q3 | -23.02 Million JPY | -105.44% |
2013 Q3 | 316.47 Million JPY | -30.14% |
2013 Q4 | 211.74 Million JPY | -33.09% |
2013 FY | 1 Billion JPY | -10.57% |
2013 Q1 | 26.41 Million JPY | -91.55% |
2013 Q2 | 452.99 Million JPY | 1614.87% |
2012 Q3 | 182.31 Million JPY | -57.43% |
2012 Q2 | 428.31 Million JPY | 110.72% |
2012 Q4 | 312.79 Million JPY | 71.57% |
2012 FY | 1.12 Billion JPY | -7.32% |
2012 Q1 | 203.25 Million JPY | 12.28% |
2011 Q2 | 367.7 Million JPY | -5.03% |
2011 FY | 1.21 Billion JPY | 145.82% |
2011 Q1 | 387.19 Million JPY | 145.52% |
2011 Q3 | 279.77 Million JPY | -23.91% |
2011 Q4 | 181.02 Million JPY | -35.3% |
2010 Q1 | 12.24 Million JPY | -91.35% |
2010 Q3 | 95.51 Million JPY | -58.31% |
2010 Q2 | 229.09 Million JPY | 1770.47% |
2010 FY | 494.55 Million JPY | 64.43% |
2010 Q4 | 157.7 Million JPY | 65.11% |
2009 Q3 | 147.15 Million JPY | -15.93% |
2009 Q1 | -163 Million JPY | 0.0% |
2009 FY | 300.77 Million JPY | 1321.32% |
2009 Q2 | 175.04 Million JPY | 207.39% |
2009 Q4 | 141.58 Million JPY | -3.79% |
2008 FY | 21.16 Million JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
HEARTSEED INC | -1.45 Billion JPY | 177.287% |
Cawachi Limited | 7.6 Billion JPY | 85.159% |
Pharmarise Holdings Corporation | 916 Million JPY | -23.154% |
Qol Holdings Co., Ltd. | 8.32 Billion JPY | 86.449% |
MatsukiyoCocokara & Co. | 75.7 Billion JPY | 98.51% |
Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 97.391% |
Create SD Holdings Co., Ltd. | 20.22 Billion JPY | 94.423% |
NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | 87.663% |
COSMOS Pharmaceutical Corporation | 31.5 Billion JPY | 96.419% |
Tsuruha Holdings Inc. | 49.2 Billion JPY | 97.707% |
Ohki Healthcare Holdings Co.,Ltd. | 2.04 Billion JPY | 44.81% |
Satudora Holdings Co.,Ltd. | 1.38 Billion JPY | 18.549% |
Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | 93.925% |
Medical System Network Co., Ltd. | 3.83 Billion JPY | 70.561% |
Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | 69.95% |
Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 96.92% |
YAKUODO HOLDINGS Co., Ltd. | 5.21 Billion JPY | 78.352% |
Genky DrugStores Co., Ltd. | 9.01 Billion JPY | 87.488% |
Ain Holdings Inc. | 20.43 Billion JPY | 94.479% |
Sundrug Co.,Ltd. | 40.99 Billion JPY | 97.248% |